pancreatic cancer

Showing NaN - NaN of 77

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (zolbetuximab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Goodyear, Arizona
  • +131 more
Jan 30, 2023

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)

Completed
  • Pancreatic Cancer
  • +2 more
  • AMG820 and pembrolizumab
  • Atlanta, Georgia
  • +14 more
Jan 18, 2023

Pancreatic Cancer Trial in Boston, Philadelphia (Gemcitabine, Nab-paclitaxel, Paricalcitol)

Active, not recruiting
  • Pancreatic Cancer
  • Boston, Massachusetts
  • +1 more
Jan 9, 2023

Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)

Active, not recruiting
  • Metastatic
  • +4 more
  • Radiotherapy
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 6, 2023

Pancreatic Cancer, Cancer of the Pancreas Trial in Philadelphia (huCART-meso cells)

Recruiting
  • Pancreatic Cancer
  • Cancer of the Pancreas
  • huCART-meso cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Dec 9, 2022

Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1

Active, not recruiting
  • Hepatocellular Carcinoma
  • +11 more
  • Part 1 TPST-1120
  • +3 more
  • San Francisco, California
  • +10 more
Nov 1, 2022

Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +5 more
  • RSC-1255 Dose Escalation
  • RSC-1255 Dose Expansion
  • Los Angeles, California
  • +5 more
Oct 24, 2022

Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer Trial in United States (SY-5609, Fulvestrant, Gemcitabine)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Gilbert, Arizona
  • +16 more
Sep 13, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Pancreatic Cancer Trial in Philadelphia (PLDR)

Recruiting
  • Pancreatic Cancer
  • PLDR
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 18, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Pancreatic Cancer in Patients With Inherited Genetic Risk

Recruiting
  • Pancreatic Cancer
  • surveillance endoscopic ultrasound or MRI of the abdomen
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 1, 2022

Pancreatic Cancer Trial in Philadelphia (Nivolumab, Nab-Paclitaxel, Gemcitabine)

Terminated
  • Pancreatic Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 19, 2022

Pancreatic Cancer Trial in Philadelphia (Paricalcitol)

Terminated
  • Pancreatic Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 29, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Pancreatic Cancer, Serous Ovarian Cancer Trial in Philadelphia (VCN-01, huCART-meso Cells)

Recruiting
  • Pancreatic Cancer
  • Serous Ovarian Cancer
  • VCN-01
  • huCART-meso Cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 17, 2022

Pancreatic Cancer Trial in United States (Directional Brachytherapy Source Implant)

Recruiting
  • Pancreatic Cancer
  • Directional Brachytherapy Source Implant
  • Chicago, Illinois
  • +4 more
Mar 1, 2022

Pancreatic Cancer Trial in United States (mFOLFIRINOX, Ramucirumab, Placebo)

Active, not recruiting
  • Pancreatic Cancer
  • Scottsdale, Arizona
  • +7 more
Feb 14, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022